METHODS Data sources and search The Preferred Reporting Items for Systematic reviews
and Meta-Analyses (PRISMA) guidelines were followed. 5 In June 2020, an electronic …

Background The presence of oral anticoagulant therapy (OAT) alone, regardless of patient
condition, is an indication for CT imaging in patients with mild traumatic brain injury (MTBI) …

Introduction Patients presenting to the Emergency Department (ED) following head injury
are frequently evaluated with an initial computed tomography scan (CT) of the brain …

Background The aim of this study was to characterize the risk of a delayed intracranial
hemorrhage (ICH) in trauma patients on direct-acting oral anticoagulants (DOACs). Methods …

Background Intracranial haemorrhage (ICH) risk after minor traumatic brain injury (mTBI) in
patients on antithrombotic treatment is unclear. We compared ICH rates in mTBI patients on …

Background Warfarin has been the oral anticoagulant of choice for the treatment of
thromboembolic disease. However, upward of 50% of all new anticoagulant prescriptions …

Background Direct oral anticoagulants (DOACs) have overtaken warfarin as the preferred
anticoagulants for stroke prevention with atrial fibrillation and for treatment of venous …

BACKGROUND The number of trauma patients on prehospital novel oral anticoagulants
(NOACs) is increasing. After an initial negative computed tomography of the head (CTH) …

Background Mild traumatic brain injury (mTBI), defined as blunt trauma to the head resulting
in witnessed loss of consciousness, definite amnesia, or witnessed disorientation with a …

Background Prognostic significance of different anticoagulants in TBI patients remains
unanswered. We aimed to compare effects of different anticoagulants on outcomes of TBI …